Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-17 | 2017-04-25 | 3148 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92678 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92681 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2017-03-15 | 2018-05-11 | 2975 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2017-03-15 | 2018-05-11 | 2978 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2017-03-15 | 2018-02-22 | 2983 |
| RATIO-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2017-03-14 | 2020-02-13 | 2419 |
| TEVA-SILDENAFIL R | 20MG | TABLET | Resolved | 2017-08-01 | 2017-09-19 | 17814 |
| TEVA-TECNAL | 330MG 50MG 40MG | CAPSULE | Resolved | 2017-03-17 | 2018-02-22 | 3151 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2017-08-01 | 2017-10-10 | 17822 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2017-08-01 | 2017-10-10 | 17827 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2019-11-14 | 2020-03-26 | 98744 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2020-07-23 | 2020-10-15 | 120911 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2020-11-27 | 2020-12-03 | 129042 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2021-06-03 | 2021-07-09 | 140366 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2021-08-27 | 2021-09-30 | 144718 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2022-03-24 | 2022-04-09 | 157250 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2022-08-18 | 2023-01-26 | 167234 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-02-09 | 2023-06-27 | 184192 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-06-16 | 2023-06-27 | 195136 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |